Methyl bromo(4-fluorophenyl)acetate - CAS 71783-54-5
Catalog: |
BB059846 |
Product Name: |
Methyl bromo(4-fluorophenyl)acetate |
CAS: |
71783-54-5 |
Synonyms: |
methyl bromo(4-fluorophenyl)acetate; Methyl 2-bromo-2-(4-fluorophenyl)acetate; Bromo-(4-fluoro-phenyl)-acetic acid methyl ester |
IUPAC Name: | methyl 2-bromo-2-(4-fluorophenyl)acetate |
Description: | Methyl bromo(4-fluorophenyl)acetate |
Molecular Weight: | 247.06 |
Molecular Formula: | C9H8BrFO2 |
Canonical SMILES: | COC(=O)C(C1=CC=C(C=C1)F)Br |
InChI: | InChI=1S/C9H8BrFO2/c1-13-9(12)8(10)6-2-4-7(11)5-3-6/h2-5,8H,1H3 |
InChI Key: | ZDQQNZRQRARBNB-UHFFFAOYSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021133749-A1 | Substituted piperazine derivatives useful as t cell activators | 20191223 |
US-10669272-B2 | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
US-2020109140-A1 | Substituted naphthyridinone compounds useful as t cell activators | 20180627 |
WO-2020006018-A1 | Substituted naphthyridinone compounds useful as t cell activators | 20180627 |
TW-202019924-A | Substituted naphthyridone compounds as T cell activators | 20180627 |
AU-2019291794-A1 | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
CN-112654621-A | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
EP-3814348-A1 | Substituted naphthyridinone compounds useful as t cell activators | 20180627 |
KR-20210024586-A | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
US-10954238-B1 | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
Complexity: | 179 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 245.96917 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 245.96917 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 26.3Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.7 |
-
Catalog: BB064634
(+)-1-(9-Fluorenyl)ethanol
Detail
-
Catalog: BB067784
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine
Detail
-
Catalog: BB056966
(((3aS,5aR,8aR,8bS)-2,2,7,7-Tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl)-L-arginine
Detail
-
Catalog: BB072386
(+)-(S)-(R)-BPPFA
Detail
-
Catalog: BB072005
(+)-(3-Bromopropyl)boronic Acid Pinanediol Ester
Detail
-
Catalog: BB054889
(+)-(2S,5R)-1-Allyl-2,5-dimethylpiperazine, (+)-Camphoric Acid Salt
Detail
-
Catalog: BB074488
((1R,3R)-3-Amino-cyclopentyl)-carbamic Acid tert-Butyl Ester
Detail
-
Catalog: BB064741
([1-(3-Fluorophenyl)-1h-imidazol-2-yl]thio)acetic acid
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS